Reading:
Post pandemic health care includes more at home care & leveraging of digital health tools

Post pandemic health care includes more at home care & leveraging of digital health tools

September 3, 2022

Written by Dr. Ramin Rafie, M.D., MBA, Advisor, Keva Health 

As the world looks to return to a sense of normalcy post pandemic, many industries have been changed forever, leading to increased leverage of technology to improve inefficiencies and create new sub-industries.  Health care is no exception as many hospitals have learned and are actively working to create hospital at home programs and centers of excellence.  Recently, Mayo & Kaiser together joined forces and raised $100 million to help develop their own hospital at home model of care to help improve some efficiencies.  Medicare’s independence at home program proved that primary care can be provided more cost efficiently in the home and in 2019, Medicare passed a law allowing all Medicare recipients to have a visiting physician in the home, a service that was previously reserved for the sickest of the homebound population.  Many new healthcare companies are taking advantage of this and centering their entire company around providing such care in the home exclusively, as it’s a better utilization of limited resources, cost effective while improving the quality of care for the patient.

Not only is technology facilitating this change by allowing portable EKGs devices to be hooked up to physician’s laptops in the home and portable EKG and U/S machines allowing such studies to be done in the home as well.  Enter AI (Artificial Intelligence) & ML (Machine Learning) which will continue to catalyze this movement by increasing the power of devices in the home.  This is where Remote Patient Monitoring comes in as devices are able to sync to smartphones and seamlessly transmit data in realtime to physicians.  Every specialty that monitors chronic conditions will benefit from this shift.

KevaHealth is able to provide such tools for asthma & COPD patients in the home & elsewhere outside the hospital and doctor’s office.  Their portable spirometry that syncs to a smartphone is providing the tools to monitor disease severity in real time while improving adherence and minimizing exacerbations.  As medicare continues to reimburse for such RPM devices and technology, this will expedite the hospital at home movement.  This technology will continue to lower hospitalizations, reduce exacerbations and usher in the new sub-industry in health care known as Prevention-As-A-Service (PAAS).

 

About Keva Health

Keva Health’s platform is integrating innovative remote monitoring functionality with evidence-based self-monitoring programs for patients with chronic respiratory diseases to improve outcomes and reduce cost. Please contact us at [email protected] for more info.



0 Comments

Leave a Reply

Related Stories

Keva Health strategy for Canadian Fires Respiratory Disease Patients
June 9, 2023

Canada Wildfires: Do’s and Don’ts for Chronic Respiratory Disease Patients

As Canada battles devastating wildfires, the impact on air quality becomes a significant concern, especially for individuals with chronic respiratory diseases. Poor air quality can exacerbate symptoms and pose serious health risks. Millions of people in North America are facing health risks due to poor air quality, as toxic wildfire smoke from Canada drifts across the continent.

April 15, 2025

Reimbursement and Coding

Telehealth has revolutionized the healthcare industry by enabling providers to deliver care remotely, enhancing accessibility and convenience for both patients and practitioners. However, understanding the complexities of reimbursement and coding in telehealth is crucial for ensuring proper billing and compliance. In this guide, we explore the key aspects of reimbursement and coding in telehealth, specifically for Keva Health and its stakeholders.

October 14, 2025

Asthma Analytics and the Importance of Digital Health

The convergence of digital health technologies and respiratory analytics is reshaping the way we manage chronic lung diseases—making care smarter, faster, and more personalized.

Arrow-up

Reg CF Disclaimer

No money or other consideration is being solicited, and if sent in response, will not be accepted. No offer to buy the securities can be accepted and no part of the purchase price can be received until the offering statement is filed and only through an intermediary’s platform. An indication of interest involves no obligation or commitment of any kind. “reserving” securities is simply an indication of interest.